Ciani O - Search Results

1

Evaluating Barriers and Facilitators to the Uptake of mHealth Apps in Cancer Care Using the Consolidated Framework for Implementation Research: Scoping Literature Review.

Ardito V, Golubev G, Ciani O, Tarricone R. Ardito V, et al. Among authors: ciani o. JMIR Cancer. 2023 Mar 30;9:e42092. doi: 10.2196/42092. JMIR Cancer. 2023. PMID: 36995750 Free PMC article. Review.

2

Pervasive technology in Neonatal Intensive Care Unit: a prototype for newborns unobtrusive monitoring.

Ciani O, Piccini L, Parini S, Rullo A, Bagnoli F, Marti P, Andreoni G. Ciani O, et al. Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:1292-5. doi: 10.1109/IEMBS.2008.4649400. Annu Int Conf IEEE Eng Med Biol Soc. 2008. PMID: 19162903

3

A more evidence based approach to the use of surrogate end points in policy making.

Ciani O, Taylor RS. Ciani O, et al. BMJ. 2011 Oct 25;343:d6498. doi: 10.1136/bmj.d6498. BMJ. 2011. PMID: 22027353 No abstract available.

4

Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers.

Ciani O, Davis S, Tappenden P, Garside R, Stein K, Cantrell A, Saad ED, Buyse M, Taylor RS. Ciani O, et al. Int J Technol Assess Health Care. 2014 Jul;30(3):312-24. doi: 10.1017/S0266462314000300. Int J Technol Assess Health Care. 2014. PMID: 25308694 Free article. Review.

5

Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses.

Ciani O, Taylor RS. Ciani O, et al. Health Econ. 2013 Feb;22(2):251-2. doi: 10.1002/hec.2826. Epub 2012 May 24. Health Econ. 2013. PMID: 22623328

6

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses.

Pavey T, Hoyle M, Ciani O, Crathorne L, Jones-Hughes T, Cooper C, Osipenko L, Venkatachalam M, Rudin C, Ukoumunne O, Garside R, Anderson R. Pavey T, et al. Among authors: ciani o. Health Technol Assess. 2012;16(42):iii-iv, 1-277. doi: 10.3310/hta16420. Health Technol Assess. 2012. PMID: 23134589 Free article. Review.

7

Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.

Ciani O, Buyse M, Garside R, Pavey T, Stein K, Sterne JA, Taylor RS. Ciani O, et al. BMJ. 2013 Jan 29;346:f457. doi: 10.1136/bmj.f457. BMJ. 2013. PMID: 23360719 Free PMC article. Review.

8

Determinants of demand for total hip and knee arthroplasty: a systematic literature review.

Mota RE, Tarricone R, Ciani O, Bridges JF, Drummond M. Mota RE, et al. Among authors: ciani o. BMC Health Serv Res. 2012 Jul 30;12:225. doi: 10.1186/1472-6963-12-225. BMC Health Serv Res. 2012. PMID: 22846144 Free PMC article. Review.

9

Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?

Ciani O, Tarricone R, Torbica A. Ciani O, et al. Health Policy. 2012 Dec;108(2-3):194-202. doi: 10.1016/j.healthpol.2012.09.017. Epub 2012 Oct 23. Health Policy. 2012. PMID: 23093020

10

An economic perspective on urinary tract infection: the "costs of resignation".

Ciani O, Grassi D, Tarricone R. Ciani O, et al. Clin Drug Investig. 2013 Apr;33(4):255-61. doi: 10.1007/s40261-013-0069-x. Clin Drug Investig. 2013. PMID: 23475540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters